BROOKE CALHOUN: Open Payments
NPI 1467968503 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 35 payments from 15 companies in 2025. Trend: 2023 $445 · 2024 $683 · 2025 $755
Food & beverage: $710Education: $45
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $107 |
| Sage Therapeutics, LLC | 4 | $84 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $71 |
| Novo Nordisk Inc | 3 | $69 |
| Hologic Sales and Service, LLC | 3 | $65 |
| Organon LLC | 2 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| SHIELD THERAPEUTICS INC | 2 | $51 |
| MILLICENT US INC | 1 | $45 |
| Exeltis, USA Inc. | 2 | $38 |
Products named: Veozah, ZURZUVAE, APTIMA, NEXPLANON, Mirena, ACCRUFER, SLYND, Phexxi.
Industry payments across MD — which companies pay providers there.
